Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Embla Medical: Recording of Q3 2025 results presentation

By Michael FriisHead of Equities
Embla Medical

Yesterday, Embla Medical’s CEO, Sveinn Sölvason, presented the Q3 2025 results, which showed an acceleration compared to the first half of the year and exceeded analyst expectations on both the top and bottom lines.

During the Q&A session, the focus was, among other topics, on the potential effects of tariffs, the drivers behind the improving momentum, and expectations for the Patient Care business, which is currently experiencing sluggish growth.

You can watch a recording of the presentation here: 

https://www.inderes.dk/videos/embla-medical-presentation-of-q3-2025-interim-report

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR agreement. /Michael Friis 14:05, 22/10/2025.

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.